TORONTO and HOUSTON, Sept. 17, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will present an update on the lead candidate from its IL-2 superkine platform, MDNA19, at the International Can

SALT LAKE CITY, Sept. 17, 2019 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced today its Australian subsidiary has been awarded a $1.37 M AUD grant from the FightMND (Fight Motor Neuron Disease) foundation of Australia. The grant will substantially fund a c

BOSTON, Sept. 17, 2019 /PRNewswire/ -- SciBite, the award-winning semantic technology company, last week hosted its annual US-based customer meeting at Novartis Institutes for BioMedical Research in Boston, MA, sparking 'clean data' discussions.

TORONTO, Sept. 17, 2019 /PRNewswire/ - ACTO and Teleflex's Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the "Best Advance in Learning Technology Implementation" category for their groundbreaking efforts to improve sales performance. The ACTO and Teleflex case study demonstrates the commercial success that life sciences companies

VANCOUVER, Sept. 17, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that it has appointed Daphne Kao as Vice President of People & Culture. Daphne joins Choom

TORONTO, Sept. 17, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce its portfolio company,

TARRYTOWN, N.Y., Sept. 17, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was added to the Dow Jones Sustainabili

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, today announced $40 million in Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world. Bayer has also entered a commercial licensing agreement

CAMBRIDGE, Mass., Sept. 17, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX) today announced an oral and

ST. LOUIS, Sept. 17, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) and Feeding America® announced today the launch of the 'Food for Today and Food for Tomorrow' resource development initiative, a program that will equip network food banks and Centene health plans with best practice guidelines for meeting the needs of individuals experiencing food insecu